Related Experiment Video
Updated: Mar 14, 2026

09:43
Microfluidic Chip Fabrication and Method to Detect Influenza
Published on: March 26, 2013
15.6K
Recent Developments in Miniaturized PCR-Microchips, Microarrays and Microdroplets
Larry J Kricka1, Eleanor S Pollak1, Paolo Fortina2
1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine , Philadelphia, PA 19104, USA.
EJIFCC
|September 30, 2016
Summary
Microchip PCR and miniaturized Polymerase Chain Reaction (PCR) offer promising point-of-care diagnostics. However, commercialization of these advanced PCR technologies lags behind digital and real-time PCR systems.
Area of Science:
- Analytical Chemistry
- Biotechnology
- Microfluidics
Background:
- Microminiaturization of assays and lab-on-a-chip devices are crucial for advanced analytical techniques.
- Point-of-care testing (POCT) demands rapid, sensitive, and portable diagnostic solutions.
- Polymerase Chain Reaction (PCR) is a foundational molecular biology technique for DNA amplification.
Purpose of the Study:
- To review recent advancements (last five years) in microchip PCR and miniaturized PCR formats.
- To highlight developments in integrated microchip PCR devices and PCR in arrays.
- To assess the current state of research and development versus commercial adoption in microchip PCR.
Main Methods:
- Review of scientific literature focusing on microchip PCR and miniaturized PCR technologies.
- Analysis of developments in reaction vessel arrays and droplet-based PCR systems.
- Comparison of progress in microchip PCR with commercial trends in digital PCR and real-time PCR arrays.
Main Results:
- Significant innovation and ingenuity in microchip PCR device design and integration.
- Continued research and development activity in miniaturized PCR formats.
- Commercialization of microchip PCR technologies is lagging compared to digital PCR and real-time PCR arrays.
Conclusions:
- Microchip PCR and miniaturized PCR show great potential for point-of-care applications.
- Despite technical progress, market adoption faces challenges compared to established PCR platforms.
- Further development is needed to bridge the gap between research innovation and commercial viability in microchip PCR.

